Aaronson ST
Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland.
ArticlePsilocybin
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial.
ArticlePsilocybin
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
ArticleKetamine
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.
PreprintKetamine
Durability of the Benefit of Vagus Nerve Stimulation in Markedly Treatment-Resistant Major Depression: A RECOVER Trial Report
ArticlePsilocybin
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
ArticlePsilocybin
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
ArticlePsilocybin
Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.
ArticlePsilocybin
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
ArticlePsilocybin
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.
ArticleKetamine
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
ArticlePsilocybin
Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.
ArticlePsilocybin
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
ArticlePsilocybin
Assessing potential of psilocybin for depressive disorders.
ArticlePsilocybin
Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.
PreprintPsilocybin
Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing
ArticlePsilocybin